Danazol

Basic Information

Item Value
DrugBank ID DB01406
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 69

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 amenorrhea (disease) KG + DL
2 benign mammary dysplasia KG + DL
3 blunt duct adenosis of breast KG + DL
4 apocrine adenosis of breast KG + DL
5 breast abscess KG + DL
6 fat necrosis of breast KG + DL
7 lactation disease KG + DL
8 breast adenosis KG + DL
9 vulvovaginitis KG + DL
10 vulvitis KG + DL
11 ulceration of vulva KG + DL
12 vulvar neoplasm KG + DL
13 postmenopausal atrophic vaginitis KG + DL
14 cervix endometriosis KG + DL
15 vaginitis (disease) KG + DL
16 renal hypoplasia, bilateral KG + DL
17 renal hypoplasia (disease) KG + DL
18 endometriosis in cutaneous scar KG + DL
19 endometriosis of rectovaginal septum and vagina KG + DL
20 leukoplakia of vagina KG + DL
21 vaginal discharge KG + DL
22 HIV infectious disease KG + DL
23 bacterial vaginosis KG + DL
24 gelatinous drop-like corneal dystrophy KG + DL
25 infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly KG + DL
26 feline acquired immunodeficiency syndrome KG + DL
27 simian immunodeficiency virus infection KG + DL
28 prostate cancer/brain cancer susceptibility KG + DL
29 fibroma of prostate KG + DL
30 benign reproductive system neoplasm KG + DL
31 Brenner tumor KG + DL
32 benign prostate phyllodes tumor KG + DL
33 AIDS KG + DL
34 neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter KG + DL
35 prostate leiomyoma KG + DL
36 male reproductive organ cancer KG + DL
37 heparin cofactor 2 deficiency KG + DL
38 ovarian endometriosis KG + DL
39 antithrombin deficiency type 2 KG + DL
40 endometrial carcinoma (disease) KG + DL
41 factor 5 excess with spontaneous thrombosis KG + DL
42 congenital human immunodeficiency virus KG + DL
43 AIDS related complex KG + DL
44 breast angiomatosis KG + DL
45 hypertrophy of breast KG + DL
46 prostate neoplasm KG + DL
47 trichomonal vulvovaginitis KG + DL
48 acne (disease) KG + DL
49 uterine corpus cancer KG + DL
50 retinal telangiectasia KG + DL

(Showing top 50 of 69 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). This report is for research purposes only and does not constitute medical advice.

This site uses Just the Docs, a documentation theme for Jekyll.